Literature DB >> 15617841

Expression of c-kit protooncogene in human hepatocellular carcinoma.

Chih-Yuan Chung1, Kun-Tu Yeh, Nicholas C Hsu, Julia Huei-Mei Chang, Jen-Tsun Lin, Huey-Ching Horng, Cheng-Shyong Chang.   

Abstract

The expression of the c-kit protooncogene in human hepatocellular carcinoma (HCC) was investigated. Immunohistochemical staining (IHC) and RT-PCR were employed to examine the protein and mRNA expression of c-kit protooncogene, respectively. IHC results demonstrated that 22 of 86 (25.6%) HCC tissue sections expressed c-kit protein. The c-kit mRNA transcript was further confirmed in all 22 IHC c-kit positive HCC tissue samples by RT-PCR. Moreover, the relationship between c-kit expression in HCC and prognosis of patients was statistically analyzed and a correlation was established. The group of patients whose HCC specimens showed positive c-kit staining exhibited better survival as compared to those patients with negative c-kit expression (p=0.021). These results suggest that c-kit expression may be a good prognostic indicator for HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617841     DOI: 10.1016/j.canlet.2004.06.045

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy.

Authors:  Mustafa Nazzal; Subhayan Sur; Robert Steele; Mousumi Khatun; Tapas Patra; Nancy Phillips; John Long; Ranjit Ray; Ratna B Ray
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.425

2.  Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.

Authors:  B Nitzsche; C Gloesenkamp; M Schrader; M Ocker; R Preissner; M Lein; A Zakrzewicz; B Hoffmann; M Höpfner
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

3.  Moving targets in hepatocellular carcinoma: hepatic progenitor cells as novel targets for tyrosine kinase inhibitors.

Authors:  Abby Siegel
Journal:  Gastroenterology       Date:  2008-08-08       Impact factor: 22.682

Review 4.  Liver cancer stem cells.

Authors:  Stewart Sell; Hyam L Leffert
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

5.  Correlation analysis of liver tumor-associated genes with liver regeneration.

Authors:  Cun-Shuan Xu; Shou-Bing Zhang; Xiao-Guang Chen; Salman Rahman
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

6.  Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors.

Authors:  Eun-Mi Son; Joo Young Kim; Soyeon An; Ki-Byung Song; Song Cheol Kim; Eunsil Yu; Seung-Mo Hong
Journal:  J Pathol Transl Med       Date:  2015-01-15

Review 7.  Targeted Diphtheria Toxin-Based Therapy: A Review Article.

Authors:  Fatemeh Shafiee; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Microbiol       Date:  2019-10-18       Impact factor: 5.640

Review 8.  C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases.

Authors:  Weina Wang; Liyan Shui; Yanning Liu; Min Zheng
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

9.  [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

Authors:  M A Kern; K Breuhahn; M Schuchmann; P Schirmacher
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.